# Amneal Pharmaceuticals, Inc. (AMRX) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Amneal Pharmaceuticals, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/AMRX/mda/fy2025/): filed 2026-02-27; accession 0001723128-26-000011 (https://www.sec.gov/Archives/edgar/data/1723128/000172312826000011/amrx-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/AMRX/mda/fy2024/): filed 2025-02-28; accession 0001723128-25-000012 (https://www.sec.gov/Archives/edgar/data/1723128/000172312825000012/amrx-20241231.htm)
- [FY 2023 MD&A](/company/AMRX/mda/fy2023/): filed 2024-03-14; accession 0001723128-24-000014 (https://www.sec.gov/Archives/edgar/data/1723128/000172312824000014/amrx-20231231.htm)
- [FY 2022 MD&A](/company/AMRX/mda/fy2022/): filed 2023-03-03; accession 0001723128-23-000009 (https://www.sec.gov/Archives/edgar/data/1723128/000172312823000009/amrx-20221231.htm)
- [FY 2021 MD&A](/company/AMRX/mda/fy2021/): filed 2022-03-01; accession 0001723128-22-000006 (https://www.sec.gov/Archives/edgar/data/1723128/000172312822000006/amrx-20211231.htm)

Back to /company/AMRX/